{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T01:06:25Z","timestamp":1780967185745,"version":"3.54.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,3,22]],"date-time":"2014-03-22T00:00:00Z","timestamp":1395446400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Psych"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s40501-014-0014-5","type":"journal-article","created":{"date-parts":[[2014,3,21]],"date-time":"2014-03-21T03:13:45Z","timestamp":1395371625000},"page":"189-203","source":"Crossref","is-referenced-by-count":56,"title":["Treatment of Gambling Disorders"],"prefix":"10.1007","volume":"1","author":[{"given":"Sarah W.","family":"Yip","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc N.","family":"Potenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,22]]},"reference":[{"key":"14_CR1","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental health disorders, Fifth Edition (DSM-5)","author":"Association AP","year":"2013","unstructured":"Association AP. Diagnostic and statistical manual of mental health disorders, Fifth Edition (DSM-5). Washington, DC: American Psychiatric Publishing; 2013."},{"key":"14_CR2","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association Committee on Nomenclature and Statistics","year":"1980","unstructured":"American Psychiatric Association Committee on Nomenclature and Statistics. Diagnostic and statistical manual of mental disorders. 3rd ed. Washington, DC: American Psychiatric Association; 1980.","edition":"3"},{"key":"14_CR3","volume-title":"Diagnostic and statistical manual of mental disorders (4th Ed.\u2013Text Revision)","author":"American Psychiatric Association Committee on Nomenclature and Statistics","year":"2000","unstructured":"American Psychiatric Association Committee on Nomenclature and Statistics. Diagnostic and statistical manual of mental disorders (4th Ed.\u2013Text Revision). Washington, DC: American Psychiatric Association; 2000."},{"key":"14_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.conb.2013.03.004","volume":"23","author":"MN Potenza","year":"2013","unstructured":"Potenza MN. Neurobiology of gambling behaviors. Curr Opin Neurobiol. 2013;23:1\u20138.","journal-title":"Curr Opin Neurobiol"},{"issue":"3","key":"14_CR5","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/add.12097","volume":"108","author":"H Bowden-Jones","year":"2013","unstructured":"Bowden-Jones H. Commentary on Petry et al. (2013): Actus Reus\u2014why it matters to pathological gambling treatment. Addiction. 2013;108(3):582\u20133.","journal-title":"Addiction"},{"key":"14_CR6","doi-asserted-by":"crossref","unstructured":"Petry NM, Blanco C, Auriacombe M, et al. An Overview of and Rationale for Changes Proposed for Pathological Gambling in DSM-5. J Gambl Stud. 2013. doi: 10.1007\/s10899-013-9370-0","DOI":"10.1007\/s10899-013-9370-0"},{"issue":"3","key":"14_CR7","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1360-0443.2012.04087.x","volume":"108","author":"NM Petry","year":"2013","unstructured":"Petry NM, Blanco C, Stinchfield R, Volberg R. An empirical evaluation of proposed changes for gambling diagnosis in the DSM-5. Addiction. 2013;108(3):575\u201381.","journal-title":"Addiction"},{"key":"14_CR8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2174\/2211556011201010067","volume":"1","author":"S Bullock","year":"2012","unstructured":"Bullock S, Potenza MN. Pathological gambling: neuropsychology and treatment. Curr Psychopharmacol. 2012;1:67\u201385. This review of pharmacological treatment options for pathological gambling provides a detailed summary of findings from studies published prior to 2013 and includes a proposed pharmacotherapy treatment algorithm which may be useful in guiding clinicians.","journal-title":"Curr Psychopharmacol"},{"issue":"4","key":"14_CR9","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00213-010-1994-5","volume":"212","author":"J Grant","year":"2010","unstructured":"Grant J, Chamberlain S, Odlaug B, et al. Memantine shows promise in reducing gambling severity and cognitive inflexibility in pathological gambling: a pilot study. Psychopharmacology. 2010;212(4):603\u201312. This pilot study suggests efficacy of memantine for the treatment of pathological gambling. It is an important \u2018proof-of-concept\u2019 study highlighting the need for further research into glutamatergic pharmacotherapies for gambling and other addictive disorders.","journal-title":"Psychopharmacology"},{"key":"14_CR10","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1176\/appi.ajp.158.9.1500","volume":"158","author":"MN Potenza","year":"2001","unstructured":"Potenza MN, Steinberg MA, McLaughlin S, et al. Gender-related differences in the charactaristics of problem gamblers using a gambling helpline. Am J Psychiatry. 2001;158:1500\u20135.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"14_CR11","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jpsychires.2010.07.010","volume":"45","author":"DT Barry","year":"2011","unstructured":"Barry DT, Stefanovics EA, Desai RA, Potenza MN. Gambling problem severity and psychiatric disorders among Hispanic and white adults: findings from a nationally representative sample. J Psychiatr Res. 2011;45(3):404\u201311.","journal-title":"J Psychiatr Res"},{"issue":"1\u20132","key":"14_CR12","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.drugalcdep.2008.09.011","volume":"100","author":"T Liu","year":"2009","unstructured":"Liu T, Maciejewski PK, Potenza MN. The relationship between recreational gambling and substance abuse\/dependence: data from a nationally representative sample. Drug Alcohol Depend. 2009;100(1\u20132):164\u20138.","journal-title":"Drug Alcohol Depend"},{"key":"14_CR13","doi-asserted-by":"crossref","unstructured":"Desai R, Maciejewski P, Pantalon M, Potenza MN. Gender differences among recreational gamblers: the association with alcohol use. Psychol Addict Behav. 2006;20(2):145\u201353.","DOI":"10.1037\/0893-164X.20.2.145"},{"issue":"4","key":"14_CR14","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00213-008-1235-3","volume":"200","author":"J Grant","year":"2008","unstructured":"Grant J, Kim S, Hollander E, Potenza M. Predicting response to opiate antagonists and placebo in the treatment of pathological gambling. Psychopharmacology. 2008;200(4):521\u20137.","journal-title":"Psychopharmacology"},{"key":"14_CR15","doi-asserted-by":"crossref","first-page":"564","DOI":"10.4088\/JCP.v66n0504","volume":"66","author":"NM Petry","year":"2005","unstructured":"Petry NM, Stinson FS, Grant BF. Co-morbidity of DSM-IV pathological gambling and other psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2005;66:564\u201374.","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"14_CR16","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archneurol.2010.65","volume":"67","author":"D Weintraub","year":"2010","unstructured":"Weintraub D, Koester J, Potenza MN, et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol. 2010;67(5):589\u201395.","journal-title":"Arch Neurol"},{"issue":"3","key":"14_CR17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1034\/j.1600-0447.2003.00162.x","volume":"108","author":"JE Grant","year":"2003","unstructured":"Grant JE, Kim SW. Comorbidity of impulse control disorders in pathological gamblers. Acta Psychiatr Scand. 2003;108(3):203\u20137.","journal-title":"Acta Psychiatr Scand"},{"key":"14_CR18","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1037\/0893-164X.21.4.431","volume":"21","author":"R Desai","year":"2007","unstructured":"Desai R, Desai M, Potenza M. Gambling, health and age: data from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Addict Behav. 2007;21:431\u201340.","journal-title":"Psychol Addict Behav"},{"issue":"12","key":"14_CR19","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1177\/0269881109106907","volume":"24","author":"S Pallanti","year":"2010","unstructured":"Pallanti S, Bernardi S, Allen A, Holander E. Serotonin function in pathological gambling: blunted growth hormone response to sumatriptan. J Psychopharmacol. 2010;24(12):1802\u20139.","journal-title":"J Psychopharmacol"},{"key":"14_CR20","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1176\/ajp.155.12.1781","volume":"155","author":"E Hollander","year":"1998","unstructured":"Hollander E, DeCaria C, Mari E, et al. Short-term single-blind fluvoxamine treatment of pathological gambling. Am J Psychiatry. 1998;155:1781\u20133.","journal-title":"Am J Psychiatry"},{"key":"14_CR21","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0006-3223(00)00241-9","volume":"47","author":"E Hollander","year":"2000","unstructured":"Hollander E, DeCaria CM, Finkell JN, Begaz T, Wong CM, Cartwright C. A randomized double-blind fluvoxamine\/placebo crossover trial in pathological gambling. Biol Psychiatry. 2000;47:813\u20137.","journal-title":"Biol Psychiatry"},{"key":"14_CR22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/10401230209147393","volume":"14","author":"C Blanco","year":"2002","unstructured":"Blanco C, Petkova E, Ibanez A, Saiz-Ruiz J. A pilot placebo-controlled study of fluvoxamine for pathological gambling. Ann Clin Psychiatry. 2002;14:9\u201315.","journal-title":"Ann Clin Psychiatry"},{"issue":"1","key":"14_CR23","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/01.wnf.0000152623.46474.07","volume":"28","author":"PN Dannon","year":"2005","unstructured":"Dannon PN, Lowengrub K, Gonopolski Y, et al. Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized. Blind-rater comparison study. Clin Neuropharmacol. 2005;28(1):6\u201310.","journal-title":"Clin Neuropharmacol"},{"issue":"2","key":"14_CR24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4088\/JCP.v66n0104","volume":"66","author":"J Saiz-Ruiz","year":"2005","unstructured":"Saiz-Ruiz J, Blanco C, Ibanez A, et al. Sertraline treatment of pathological gambling: a pilot study. J Clin Psychiatry. 2005;66(2):28\u201333.","journal-title":"J Clin Psychiatry"},{"key":"14_CR25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00004850-200607000-00002","volume":"21","author":"JE Grant","year":"2006","unstructured":"Grant JE, Potenza MN. Escitalopram treatment of pathological gambling with co-occurring anxiety: an open-label pilot study with double-blind discontinuation. Int Clin Psychopharmacol. 2006;21:203\u20139.","journal-title":"Int Clin Psychopharmacol"},{"issue":"1","key":"14_CR26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/14459795.2011.559647","volume":"11","author":"H Myrseth","year":"2011","unstructured":"Myrseth H, Molde H, St\u00f8ylen IJ, et al. A pilot study of CBT versus escitalopram combined with CBT in the treatment of pathological gamblers. Int Gambl Stud. 2011;11(1):121\u201341.","journal-title":"Int Gambl Stud"},{"key":"14_CR27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00004850-200307000-00007","volume":"18","author":"J Grant","year":"2003","unstructured":"Grant J, Kim SW, Potenza MN, Blanco C, Ibanez A, Stevens LC, et al. Paroxetine treatment of pathological gambling: a multi-center randomized controlled trial. Int Clin Psychopharmacol. 2003;18:243\u20139.","journal-title":"Int Clin Psychopharmacol"},{"issue":"6","key":"14_CR28","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4088\/JCP.v63n0606","volume":"63","author":"S Kim","year":"2002","unstructured":"Kim S, Grant JE, Adson DE, Shin YC, Zaninelli R. A double-blind, placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling disorder. J Clin Psychiatry. 2002;63(6):501\u20137.","journal-title":"J Clin Psychiatry"},{"key":"14_CR29","unstructured":"Physicians\u2019 Desk Reference. http:\/\/www.pdr.net . July 2013."},{"key":"14_CR30","volume-title":"Red Book","author":"PDR Network","year":"2010","unstructured":"Network PDR. Red Book. 114th ed. Montvale: PDR Network; 2010.","edition":"114"},{"key":"14_CR31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1176\/appi.ajp.162.1.137","volume":"162","author":"E Hollander","year":"2005","unstructured":"Hollander E, Pallanti S, Allen A, et al. Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders? Am J Psychiatry. 2005;162:137\u201345.","journal-title":"Am J Psychiatry"},{"issue":"7","key":"14_CR32","doi-asserted-by":"crossref","first-page":"559","DOI":"10.4088\/JCP.v63n0704","volume":"63","author":"S Pallanti","year":"2002","unstructured":"Pallanti S, Quercioli L, Sood E, Hollander E. Lithium and valproate treatment of pathological gambling: a randomized single-blind study. J Clin Psychiatry. 2002;63(7):559\u201364.","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"14_CR33","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1360-0443.2010.03126.x","volume":"106","author":"J Linnet","year":"2011","unstructured":"Linnet J, M\u00f8ller A, Peterson E, et al. Dopamine release in ventral striatum during Iowa Gambling Task performance is associated with increased excitement levels in pathological gambling. Addiction. 2011;106(2):383\u201390.","journal-title":"Addiction"},{"issue":"2","key":"14_CR34","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/01.jcp.0000264985.25109.25","volume":"27","author":"D Black","year":"2007","unstructured":"Black D, Arndt S, Coryell W, et al. Bupropion in the treatment of pathological gambling: a randomized, double-blind, placebo-controlles, flexible-dose study. J Clin Psychopharmacol. 2007;27(2):143\u201350.","journal-title":"J Clin Psychopharmacol"},{"issue":"3\u20134","key":"14_CR35","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1527-3458.2006.00178.x","volume":"12","author":"LP Dwoskin","year":"2006","unstructured":"Dwoskin LP, Rauhut AS, King-Pospisil KA, Bardo MT. Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent. CNS Drug Rev. 2006;12(3\u20134):178\u2013207.","journal-title":"CNS Drug Rev"},{"issue":"12","key":"14_CR36","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1517\/14656566.6.12.2077","volume":"6","author":"P Buckley","year":"2005","unstructured":"Buckley P. Olanzapine: a critical review of recent literature. Expert Opin Pharmacother. 2005;6(12):2077\u201389.","journal-title":"Expert Opin Pharmacother"},{"issue":"3","key":"14_CR37","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4088\/JCP.v69n0314","volume":"69","author":"S McElroy","year":"2008","unstructured":"McElroy S, Nelson E, Welge J, et al. Olanzapine in the treatment of pathological gambling: a negative randomized placebo-controlled trial. J Clin Psychiatry. 2008;69(3):433\u201340.","journal-title":"J Clin Psychiatry"},{"key":"14_CR38","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.pbb.2007.12.025","volume":"89","author":"T Fong","year":"2008","unstructured":"Fong T, Kalechstein A, Bernhard B, et al. A double-blind, placebo-controlled trial of olanzapine for the treatment of video poker pathological gamblers. Pharmacol Biochem Behav. 2008;89:298\u2013303.","journal-title":"Pharmacol Biochem Behav"},{"issue":"11","key":"14_CR39","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0006-3223(01)01079-4","volume":"49","author":"SW Kim","year":"2001","unstructured":"Kim SW, Grant JE, Adson DE, Shin YC. Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry. 2001;49(11):914\u201321.","journal-title":"Biol Psychiatry"},{"issue":"5","key":"14_CR40","doi-asserted-by":"crossref","first-page":"783","DOI":"10.4088\/JCP.v69n0511","volume":"69","author":"J Grant","year":"2008","unstructured":"Grant J, Kim S, Hartman B. A double-blind, placebo-controlled study of the opioid antagonist naltrexone in the treatment of pathological gambling urges. J Clin Psychiatry. 2008;69(5):783\u20139.","journal-title":"J Clin Psychiatry"},{"key":"14_CR41","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1176\/appi.ajp.163.2.303","volume":"163","author":"JE Grant","year":"2006","unstructured":"Grant JE, Potenza MN, Hollander E, et al. Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am J Psychiatry. 2006;163:303\u201312.","journal-title":"Am J Psychiatry"},{"issue":"4","key":"14_CR42","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1192\/bjp.bp.110.078105","volume":"197","author":"JE Grant","year":"2010","unstructured":"Grant JE, Odlaug BL, Potenza MN, et al. Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study. Br J Psychiatry. 2010;197(4):330\u20131. In conjunction with prior studies, this placebo-controlled study suggests significant efficacy for pharmacotherapies targeting the opioid system in the treamtent of gambling disorder.","journal-title":"Br J Psychiatry"},{"key":"14_CR43","unstructured":"http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2006\/020459s006lbl.pdf . Retrieved June 2013."},{"key":"14_CR44","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrn2515","volume":"10","author":"P Kalivas","year":"2009","unstructured":"Kalivas P. The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci. 2009;10:561\u201372.","journal-title":"Nat Rev Neurosci"},{"key":"14_CR45","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/mp.2011.46","volume":"16","author":"P Kalivas","year":"2011","unstructured":"Kalivas P, Volkow N. New medications for drug addiction hiding in glutamatergic neuroplasticity. Mol Psychiatry. 2011;16:974\u201386.","journal-title":"Mol Psychiatry"},{"issue":"2","key":"14_CR46","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/15622975.2011.560964","volume":"14","author":"H Berlin","year":"2013","unstructured":"Berlin H, Braun A, Simeon D, et al. A double-blind, placebo-controlled trial of topiramate for pathological gambling. World J Biol Psychiatry. 2013;14(2):121\u20138. This is the first randomized, controled trial of topiramate. Results do not suggest direct effects on gambling symptoms, but reductions in impulsivity were suggested.","journal-title":"World J Biol Psychiatry"},{"issue":"3","key":"14_CR47","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/ana.22029","volume":"68","author":"A Thomas","year":"2010","unstructured":"Thomas A, Bonanni L, Gambi F, et al. Pathological gambling in Parkinson disease is reduced by amantadine. Ann Neurol. 2010;68(3):400\u20134.","journal-title":"Ann Neurol"},{"issue":"6","key":"14_CR48","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.22164","volume":"68","author":"D Weintraub","year":"2010","unstructured":"Weintraub D, Sohr M, Potenza MN, et al. Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study. Ann Neurol. 2010;68(6):963\u20138.","journal-title":"Ann Neurol"},{"issue":"3","key":"14_CR49","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neulet.2009.03.043","volume":"454","author":"H Wageningen van","year":"2009","unstructured":"van Wageningen H, J\u00f8rgensen HA, Specht K, Hugdahl K. Evidence for glutamatergic neurotransmission in cognitive control in an auditory attention task. Neurosci Lett. 2009;454(3):171\u20135.","journal-title":"Neurosci Lett"},{"issue":"6","key":"14_CR50","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.biopsych.2006.11.021","volume":"62","author":"JE Grant","year":"2007","unstructured":"Grant JE, Kim SW, Odlaug BL. N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study. Biol Psychiatry. 2007;62(6):652\u20137.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"14_CR51","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4088\/JCP.13m08411","volume":"75","author":"JE Grant","year":"2014","unstructured":"Grant JE, Odlaug BL, Chamberlain SR, et al. A randomized, placebo-controlled trial of N-acetylcysteine plus imaginal desensitization for nicotine-dependent pathological gamblers. J Clin Psychiatry. 2014;75(1):39\u201345.","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"14_CR52","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/JCP.0b013e3181bfdb79","volume":"29","author":"G Rubio","year":"2009","unstructured":"Rubio G, Mart\u00ednez-Gras I, Manzanares J. Modulation of impulsivity by Topiramate: implications for the treatment of alcohol dependence. J Clin Psychopharmacol. 2009;29(6):584\u20139. doi: 10.1097\/JCP.1090b1013e3181bfdb1079 .","journal-title":"J Clin Psychopharmacol"},{"key":"14_CR53","volume-title":"Physicians\u2019 desk reference","author":"PDR Network","year":"2013","unstructured":"PDR Network. Physicians\u2019 desk reference. 67th ed. Montvale: PDR Network; 2013.","edition":"67"},{"key":"14_CR54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/ADT.0b013e31803155c2","volume":"7","author":"JA Brewer","year":"2008","unstructured":"Brewer JA, Grant JE, Potenza MN. The treatment of pathological gambling. Addict Disord Treat. 2008;7:1\u201313.","journal-title":"Addict Disord Treat"},{"key":"14_CR55","first-page":"CD008937","volume":"11","author":"S Cowlishaw","year":"2012","unstructured":"Cowlishaw S, Merkouris S, Dowling N, et al. Psychological therapies for pathological and problem gambling. Cochrane Database Syst Rev. 2012;11:CD008937. This is a well-conducted, systematic review of behavioral therapies for gambling problems. Data suggest efficacy for cognitive behavioral therapies and possibly motivational interviewing; however more data on different treatments is needed.","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"14_CR56","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.brat.2009.04.002","volume":"47","author":"P Gooding","year":"2009","unstructured":"Gooding P, Tarrier N. A systematic review and meta-analysis of cognitive-behavioural interventions to reduce problem gambling: hedging our bets? Behav Res Ther. 2009;47(7):592\u2013607.","journal-title":"Behav Res Ther"},{"issue":"2","key":"14_CR57","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/16506070903190245","volume":"39","author":"P Carlbring","year":"2010","unstructured":"Carlbring P, Jonsson J, Josephson H, Forsberg L. Motivational interviewing versus cognitive behavioral group therapy in the treatment of problem and pathological gambling: a randomized controlled trial. Cogn Behav Ther. 2010;39(2):92\u2013103.","journal-title":"Cogn Behav Ther"},{"issue":"3","key":"14_CR58","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1192\/bjp.bp.108.062414","volume":"195","author":"JE Grant","year":"2009","unstructured":"Grant JE, Donahue CB, Odlaug BL, et al. Imaginal desensitisation plus motivational interviewing for pathological gambling: randomised controlled trial. Br J Psychiatry. 2009;195(3):266\u20137.","journal-title":"Br J Psychiatry"},{"issue":"9","key":"14_CR59","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa060281","volume":"355","author":"G Deuschl","year":"2006","unstructured":"Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson\u2019s disease. N Engl J Med. 2006;355(9):896\u2013908.","journal-title":"N Engl J Med"},{"issue":"6","key":"14_CR60","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.parkreldis.2011.02.013","volume":"17","author":"M Broen","year":"2011","unstructured":"Broen M, Duits A, Visser-Vandewalle V, et al. Impulse control and related disorders in Parkinson\u2019s disease patients treated with bilateral subthalamic nucleus stimulation: a review. Parkinsonism Relat Disord. 2011;17(6):413\u20137.","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"14_CR61","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2217\/npy.11.11","volume":"1","author":"RF Leeman","year":"2011","unstructured":"Leeman RF, Potenza MN. Impulse control disorders in Parkinson\u2019s disease: clinical characteristics and implications. Neuropsychiatry (Lond). 2011;1(2):133\u201347.","journal-title":"Neuropsychiatry (Lond)"},{"key":"14_CR62","unstructured":"http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00927563 . June 2013."},{"issue":"11","key":"14_CR63","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.euroneuro.2013.07.008","volume":"23","author":"JE Grant","year":"2013","unstructured":"Grant JE, Odlaug BL, Chamberlain SR, et al. A proof of concept study of tolcapone for pathological gambling: relationships with COMT genotype and brain activation. Eur Neuropsychopharmacol. 2013;23(11):1587\u201396.","journal-title":"Eur Neuropsychopharmacol"},{"key":"14_CR64","unstructured":"http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01215357 . June 2013."},{"issue":"6","key":"14_CR65","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1521-0391.2011.00180.x","volume":"20","author":"SW Yip","year":"2011","unstructured":"Yip SW, Desai RA, Steinberg MA, et al. Health\/functioning characteristics, gambling behaviors, and gambling-related motivations in adolescents stratified by gambling problem severity: findings from a high school survey. Am J Addict. 2011;20(6):495\u2013508.","journal-title":"Am J Addict"},{"issue":"10","key":"14_CR66","first-page":"40","volume":"3","author":"MK Wilber","year":"2006","unstructured":"Wilber MK, Potenza MN. Adolescent gambling: research and clinical implications. Psychiatry. 2006;3(10):40\u20138.","journal-title":"Psychiatry"},{"issue":"2","key":"14_CR67","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jaac.2010.11.006","volume":"50","author":"MN Potenza","year":"2011","unstructured":"Potenza MN, Wareham JD, Steinberg MA, et al. Correlates of at-risk\/problem internet gambling in adolescents. J Am Acad Child Adolesc Psychiatry. 2011;50(2):150\u2013159.e153.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"14_CR68","first-page":"129","volume":"22","author":"JE Grant","year":"2010","unstructured":"Grant JE, Potenza MN. Pharmacological treatment of adolescent pathological gambling. Int J Adolesc Med Health. 2010;22(1):129\u201338.","journal-title":"Int J Adolesc Med Health"}],"container-title":["Current Treatment Options in Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40501-014-0014-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40501-014-0014-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40501-014-0014-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T22:47:50Z","timestamp":1559515670000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40501-014-0014-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,22]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["14"],"URL":"https:\/\/doi.org\/10.1007\/s40501-014-0014-5","relation":{},"ISSN":["2196-3061"],"issn-type":[{"value":"2196-3061","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,22]]}}}